Provided by Tiger Trade Technology Pte. Ltd.

Nuwellis, Inc.

1.16
+0.04003.57%
Post-market: 1.15-0.0100-0.86%19:59 EDT
Volume:226.05K
Turnover:259.75K
Market Cap:4.23M
PE:-0.01
High:1.18
Open:1.11
Low:1.11
Close:1.12
52wk High:187.60
52wk Low:1.11
Shares:3.65M
Float Shares:3.42M
Volume Ratio:0.59
T/O Rate:6.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-145.7988
EPS(LYR):-25.3816
ROE:-609.44%
ROA:-87.83%
PB:-2.06
PE(LYR):-0.05

Loading ...

Corcept Therapeutics (CORT) Stock Soars 22% After Hours: Here's What You Need To Know

Benzinga Earnings
·
Jul 30

Nuwellis (NUWE) Stock Rallies 90% After Hours: Here's Why it is Trending

Benzinga Earnings
·
Jul 30

Nuwellis Expands Wisconsin Pediatric Footprint With Aquadex SmartFlow System

MT Newswires Live
·
Jul 28

Nuwellis Announces Preliminary Q2 Earnings With YoY Q2 Revenue Growth Of 14% And H2 Revenue Growth Of 20%

Benzinga Earnings
·
Jul 27

Nuwellis Sees Q2 2026 Revenue up 14%, H1 up 20% on Preliminary Results

Reuters
·
Jul 27

Nuwellis - Announces Preliminary H1 2026 Revenue Growth of 20% Year-Over-Year

THOMSON REUTERS
·
Jul 27

Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth

THOMSON REUTERS
·
Jul 27

Nuwellis Held Virtual Special Shareholder Meeting, 46.2% of Shares Represented

Reuters
·
Jul 25

Nuwellis awarded U.S. patent for Dual Lumen Catheter

TIPRANKS
·
Jul 16

Nuwellis Wins US Patent for Dual-lumen Catheter Used in Extracorporeal Therapies

Reuters
·
Jul 16

Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies

THOMSON REUTERS
·
Jul 16

Nuwellis - Awarded U.S. Patent for Dual Lumen Catheter on July 14, 2026

THOMSON REUTERS
·
Jul 16

Nuwellis Files Form 3 Initial Beneficial Ownership Statement for President, CEO Michael Kendrick Mccormick

Reuters
·
Jul 02

Nuwellis Inc trading halted, news pending

TIPRANKS
·
Jun 26

Nuwellis’ REVERSE-HF Trial Termination: What It Means for NUWE Investors

TIPRANKS
·
Jun 26

Incoming Nuwellis CEO Mike Mccormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders

THOMSON REUTERS
·
Jun 24

Top Premarket Decliners

MT Newswires Live
·
Jun 24

Nuwellis - Reverse Stock Split Effective June 25, 2026; Split-adj Trading Begins June 26, 2026 - SEC Filing

THOMSON REUTERS
·
Jun 24

Nuwellis - on June 16, Approves One-for-thirty-five Reverse Stock Split of Common Stock - SEC Filing

THOMSON REUTERS
·
Jun 24

Nuwellis highlights clinical utility of its Aquadex SmartFlow system

TIPRANKS
·
Jun 18